Nasdaq
LXEO
Lexeo Therapeutics, Inc.
- Health Care
- Listed 2023
- 1 day
- +2.2%
- 1 month
- −5.0%
- 1 year
- −4.4%
$4.55 · Mkt cap $357M
At the 6 Aug 2026 close
Nasdaq
Lexeo Therapeutics, Inc.
$4.55 · Mkt cap $357M
At the 6 Aug 2026 close
Lexeo Therapeutics, Inc. trades under the ticker LXEO on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2023. Its market capitalisation is $357M. The last closing price was $4.55, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −4.4%, and −5.0% over the past month. Returns are price returns and exclude dividends.
This page exists because LXEO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.